An official website of the United States government
NIH Guide: Weekly Index for February 3, 2023
Weekly NIH Funding Opportunities and Notices
February 3, 2023
Policy Notices
-
Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: August/October 2023 Councils
(NOT-OD-23-066)National Institutes of HealthAgency for Healthcare Research and QualityNational Institute for Occupational Safety and Health
-
Clarification and Guidance for Applicants Preparing Applications for the Spring 2023 Due Dates During the COVID-19 Pandemic
(NOT-OD-23-067)National Institutes of Health
-
Reminder: NIH Natural Disaster Policy California Flooding, Landslides, and Mudslides and Alabama Storms, Straight-line Winds, and Tornadoes
(NOT-OD-23-069)National Institutes of Health
-
Notice of Fiscal Policies in Effect for FY 2023
(NOT-OD-23-071)National Institutes of Health
-
Notice of Legislative Mandates in Effect for FY 2023
(NOT-OD-23-072)National Institutes of Health
-
Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels Effective for Fiscal Year 2023
(NOT-OD-23-076)National Institutes of HealthAgency for Healthcare Research and Quality
General Notices
-
Notice of content visibility for tables located in Part 2. Full Text of Announcement in RFA-FD-23-027 "Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials Not Allowed"
(NOT-FD-23-006)Food and Drug Administration
-
Notice announcing Webinar and Frequently Asked Questions (FAQs) for PAR-23-037 NICHD Multisite Clinical Research: Leveraging Network Infrastructure to Advance Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities
(NOT-HD-23-002)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
Notice of NHGRI Participation in NOT-OD-23-044 "Notice of Special Interest (NOSI): Support for existing data repositories to align with FAIR and TRUST principles and evaluate usage, utility, and impact
(NOT-HG-23-019)National Human Genome Research Institute
-
Notice of Information for RFA-OD-21-003, "Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)"
(NOT-OD-23-078)Office of Disease Prevention
-
Notice of Information for RFA-OD-21-004, "Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed)"
(NOT-OD-23-079)Office of Disease Prevention
-
Request for Information (RFI): Seeking Stakeholder Input on Enhancing Diversity, Equity, Inclusion, and Accessibility Across NIAID Extramural Activities
(NOT-AI-23-017)National Institute of Allergy and Infectious Diseases
-
Request for Information on Existing Data Sharing Processes for NIH-Funded Research
(NOT-CA-23-023)National Cancer Institute
-
Request for Information (RFI): Input for developing the 2024-2028 National Institute of Environmental Health Sciences Strategic Plan
(NOT-ES-23-005)National Institute of Environmental Health Sciences
-
Request for Information (RFI): Gaps and Opportunities in Global Mental Health Research
(NOT-MH-23-175)National Institute of Mental Health
Notice of Changes to Funding Opportunities
-
Notice of NIAAA's participation in NOT-OD-23-044 "Notice of Special Interest (NOSI): Support for existing data repositories to align with FAIR and TRUST principles and evaluate usage, utility, and impact"
(NOT-AA-23-007)National Institute on Alcohol Abuse and Alcoholism
-
Notice of the National Eye Institute participation in NOT-OD-23-044, "Notice of Special Interest (NOSI): Support for existing data repositories to align with FAIR and TRUST principles and evaluate usage, utility, and impact
(NOT-EY-23-004)National Eye Institute
-
Notice of Clarification for the Research Scope in RFA-HD-24-002 "Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed)"
(NOT-HD-23-004)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
Notice of Early Expiration of NOT-HL-21-017, "Notice of Special Interest (NOSI): Integrative Omics Analysis of NHLBI TOPMed Data (Parent R01 Clinical Trial Not Allowed)"
(NOT-HL-23-074)National Heart, Lung, and Blood Institute
-
Notice to expire NIHs Continuity Supplements (NOT-OD-20-054 and NOT-OD-20-055)
(NOT-OD-23-074)Office of the Director, NIH
Notices of Special Interest
-
Notice of Special Interest (NOSI): Development of Functional Assay Sites to Evaluate Candidate -Omics Variants Associated with Heart, Lung, Blood, or Sleep Disease (R01, R41, R42, R43, R44)
(NOT-HL-23-066)National Heart, Lung, and Blood Institute
-
Notice of Special Interest (NOSI) for Administrative Supplements: Harmonization and Joint Analysis of Human Brain Single-Cell Datasets
(NOT-NS-23-042)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Behavioral and Social Sciences Research
-
Notice of Special Interest (NOSI): Revision Applications to add a Curation and Informatics Component to existing Animal and Biological Material Resource Centers (P40) (Clinical Trials Not Allowed)
(NOT-OD-23-068)Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Funding Opportunities
-
Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed)
(PAR-22-262)Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure ProgramsApplication Receipt Date(s): January 7, 2024
-
Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional)
(PAR-23-077)National Institute of General Medical SciencesApplication Receipt Date(s): Multiple dates, see announcement.
-
Data Harmonization, Curation and Secondary Analysis of Existing Clinical Datasets (R61/R33 Clinical Trial Not Allowed)
(PAR-23-089)National Institute of Neurological Disorders and StrokeApplication Receipt Date(s): March 14, 2024
-
Career Enhancement Award to Advance Research on Firearm Injury and Mortality Prevention (K18 Independent Clinical Trial Required)
(PAR-23-107)Office of Behavioral and Social Sciences ResearchNational Institute on AgingNational Institute on Drug AbuseNational Institute of Mental HealthNational Institute of Nursing ResearchNational Center for Complementary and Integrative HealthOffice of Research on Women's HealthOffice of Disease PreventionNational Institute on Minority Health and Health DisparitiesApplication Receipt Date(s): March 17, 2023
-
Career Enhancement Award to Advance Research on Firearm Injury and Mortality Prevention (K18 Independent Clinical Trial Not Allowed)
(PAR-23-108)Office of Behavioral and Social Sciences ResearchNational Institute on AgingNational Institute on Drug AbuseNational Institute of Mental HealthNational Institute of Nursing ResearchNational Center for Complementary and Integrative HealthOffice of Research on Women's HealthOffice of Disease PreventionNational Institute on Minority Health and Health DisparitiesApplication Receipt Date(s): March 17, 2023
-
NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
(PAR-23-111)National Institute on Minority Health and Health DisparitiesApplication Receipt Date(s): May 7, 2026
-
Team Science Approaches Integrating Experimental and Computational Brain Aging Models (R21/R33 Clinical Trial Not Allowed)
(RFA-AG-24-018)National Institute on AgingApplication Receipt Date(s): September 22, 2023
-
Research on Bioethical Issues Related to Bionic and Robotic Device Development and Translation (R21 Clinical Trial Optional)
(RFA-EB-23-001)National Institute of Biomedical Imaging and BioengineeringOffice of the Director, NIHApplication Receipt Date(s): April 27, 2023
-
FDA OMHHE Health Equity Innovation Award: Racial & Ethnic Minority Acceleration Consortium for Health Equity (REACH) (U01) Clinical Trials Optional
(RFA-FD-23-010)Food and Drug AdministrationApplication Receipt Date(s): April 6, 2023
-
Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
(RFA-MD-23-002)National Institute on Minority Health and Health DisparitiesNational Institute of Dental and Craniofacial ResearchNational Institute of Neurological Disorders and StrokeNational Center for Advancing Translational SciencesNational Center for Advancing Translational SciencesApplication Receipt Date(s): September 6, 2023
-
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
(RFA-MD-23-003)National Institute on Minority Health and Health DisparitiesNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Heart, Lung, and Blood InstituteNational Institute of Neurological Disorders and StrokeNational Center for Advancing Translational SciencesNational Institute of Biomedical Imaging and BioengineeringNational Center for Advancing Translational SciencesApplication Receipt Date(s): September 6, 2023
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: March 24, 2025
For technical issues E-mail OER Webmaster